These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 3037680)

  • 1. Antibodies to the herpes simplex virus type-2-induced tumor-associated antigen AG-4 as markers of recurrence in cervical cancer.
    te Velde ER; Aurelian L
    Tumour Biol; 1987; 8(1):26-33. PubMed ID: 3037680
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Presence of herpes simplex virus type 2 (HSV-2) antibodies and antigens in patients with cervical carcinoma in Thailand.
    Puthavathana P; Srivatanakul P; Thanapatra S; Kosiyatrakul T; Phitakpraiwan P
    J Med Assoc Thai; 1980 Oct; 63(10):560-7. PubMed ID: 6255050
    [No Abstract]   [Full Text] [Related]  

  • 3. AG-4 complement-fixing antibodies in cervical cancer and herpes-infected patients using local herpes simplex virus type 2.
    Arsenakis M; Georgiou GM; Welsh JK; Cauchi MN; May JT
    Int J Cancer; 1980 Jan; 25(1):67-71. PubMed ID: 6249764
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IgM antibody to a tumor-associated antigen (AG-4) induced by herpes simplex virus type 2: its use in location of the antigen in infected cells.
    Aurelian L; Smith MF; Cornish DJ
    J Natl Cancer Inst; 1976 Mar; 56(3):471-7. PubMed ID: 176392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of antibodies against herpes simplex and adenovirus in oral and cervical cancer patients--a preliminary report.
    Kumari TV; Shanmugam J; Prabha B; Vasudevan DM
    Indian J Med Res; 1982 Apr; 75():590-2. PubMed ID: 6286474
    [No Abstract]   [Full Text] [Related]  

  • 6. Long-term follow-up studies on herpes simplex antibodies in the course of cervical cancer: patterns of neutralizing antibodies.
    Christenson B; Espmark A
    Am J Epidemiol; 1977 Apr; 105(4):296-302. PubMed ID: 192072
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term follow-up studies on herpes simplex antibodies in the course of cervical cancer. II. Antibodies to surface antigen of Herpes simplex virus infected cells.
    Christenson B; Espmark A
    Int J Cancer; 1976 Mar; 17(3):318-25. PubMed ID: 176115
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Herpesvirus type 2-induced tumour-specific antigen (AG-4) and specific antibody in patients with cervical cancer and controls.
    Aurelian L; Cornish JD; Smith MF
    IARC Sci Publ (1971); 1975; (11 Pt 2):79-87. PubMed ID: 191387
    [No Abstract]   [Full Text] [Related]  

  • 9. [Serological aspects of the relation between herpes virus and cervico-uterine cancer].
    Suárez M; Del Campo G; Ojeda JM
    Rev Chil Obstet Ginecol; 1983; 48(1):11-5. PubMed ID: 6099904
    [No Abstract]   [Full Text] [Related]  

  • 10. Prevalence of antibodies to herpes simplex virus and frequency of HLA antigens in patients with preinvasive and invasive cervical cancer.
    Vass-Sørensen M; Abeler V; Berle E; Pedersen B; Davy M; Thorsby E; Norrild B
    Gynecol Oncol; 1984 Jul; 18(3):349-58. PubMed ID: 6086470
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Application of indirect hemagglutination test to measurement of type specific antibody to herpes simplex virus in human sera.
    Ohashi M; Ozaki Y
    Microbiol Immunol; 1979; 23(8):801-4. PubMed ID: 232237
    [No Abstract]   [Full Text] [Related]  

  • 12. Immunity, herpes simplex virus, and cervical carcinoma.
    Mumford DM; Kaufman RH; McCormick N
    Surg Clin North Am; 1978 Feb; 58(1):39-54. PubMed ID: 205961
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical value of routine serum squamous cell carcinoma antigen in follow-up of patients with early-stage cervical cancer.
    Esajas MD; Duk JM; de Bruijn HW; Aalders JG; Willemse PH; Sluiter W; Pras B; ten Hoor K; Hollema H; van der Zee AG
    J Clin Oncol; 2001 Oct; 19(19):3960-6. PubMed ID: 11579117
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation between immune complexes and herpes simplex virus (HSV)-tumor associated antigen (TAA) in human cancer sera.
    Cocchiara R; Tarro G; Flaminio G; Geraci D
    Cell Mol Biol; 1983; 29(5):397-403. PubMed ID: 6313196
    [No Abstract]   [Full Text] [Related]  

  • 15. Herpes simplex virus. An expanding relationship to human cancer.
    Smith JW
    J Reprod Med; 1983 Feb; 28(2):116-22. PubMed ID: 6300393
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibody to HSV-2 induced tumor specific antigens in serums from patients with cervical carcinoma.
    Aurelian L; Schumann B; Marcus RL; Davis HJ
    Science; 1973 Jul; 181(4095):161-4. PubMed ID: 4711734
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Viruses and gynecologic cancers: herpesvirus protein (ICP 10/AG-4), a cervical tumor antigen that fulfills the criteria for a marker of carcinogenicity.
    Aurelian L; Kessler II; Rosenshein NB; Barbour G
    Cancer; 1981 Jul; 48(2 Suppl):455-71. PubMed ID: 7023662
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Herpes simplex virus type 2 antibodies in the husbans of women with cervical cancer].
    Kunkel M; Oberender H; Rätz KH; Hofmann R; Gärtner L; Heise H
    Z Gesamte Hyg; 1979 Aug; 25(8):597-9. PubMed ID: 228506
    [No Abstract]   [Full Text] [Related]  

  • 19. Association of herpes simplex type 2 virus with cervical cancer of the uterus.
    Kao CL; Chen YH; Tang MC; Wen HK; Hsia S
    Taiwan Yi Xue Hui Za Zhi; 1974 Feb; 73(2):122-7. PubMed ID: 4368434
    [No Abstract]   [Full Text] [Related]  

  • 20. Antibody to herpes simplex virus type 2-induced early antigens and its radioimmunoassay with sera of cervical carcinoma patients.
    Ito H; Kurihara S; Nishimura C
    Kitasato Arch Exp Med; 1978 Jun; 51(1-2):1-13. PubMed ID: 225600
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.